Page last updated: 2024-10-31

midazolam and Sarcoma, Epithelioid

midazolam has been researched along with Sarcoma, Epithelioid in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Postovsky, S1
Moaed, B1
Krivoy, E1
Ofir, R1
Ben Arush, MW1
Bley, CR1
Roos, M1
Price, J1
Ruess-Melzer, K1
Buchholz, J1
Poirier, V1
Kaser-Hotz, B1

Other Studies

2 other studies available for midazolam and Sarcoma, Epithelioid

ArticleYear
Practice of palliative sedation in children with brain tumors and sarcomas at the end of life.
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:6

    Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Consciousness; Glioma

2007
Clinical assessment of repeated propofol-associated anesthesia in cats.
    Journal of the American Veterinary Medical Association, 2007, Nov-01, Volume: 231, Issue:9

    Topics: Anesthesia, Intravenous; Anesthetics, Intravenous; Animals; Blood Pressure; Carcinoma, Squamous Cell

2007